Hangzhou, China

Chuang Sun

This inventor holds 1 USPTO granted patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuang Sun. Retrieved from https://idiyas.com/inventor/chuang-sun-mkesdpe0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chuang Sun: Innovator in Cancer Research

Introduction

Chuang Sun is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of cancer research through his innovative work. His expertise and dedication have led to the development of groundbreaking technologies aimed at improving cancer treatment.

Latest Patents

Chuang Sun holds a patent for "Methods and Compositions for Chimeric Antigen Receptor Targeting Cancer Cells." This patent represents a crucial advancement in the fight against cancer, showcasing his commitment to developing effective therapies.

Career Highlights

Chuang Sun is affiliated with the University of North Carolina at Chapel Hill, where he continues to engage in cutting-edge research. His work has garnered attention for its potential to revolutionize cancer treatment methodologies.

Collaborations

Chuang has collaborated with notable colleagues such as Gianpietro Dotti and Peishun Shou. These partnerships have further enhanced the impact of his research and innovations in the field.

Conclusion

Chuang Sun's contributions to cancer research through his patent and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical science and cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…